{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2016-05-04&tablingMemberConstituency=Reigate&max-answer.dateOfAnswer=2019-02-06", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.dateOfAnswer=2016-05-04&tablingMemberConstituency=Reigate&max-answer.dateOfAnswer=2019-02-06", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2016-05-04&tablingMemberConstituency=Reigate&_metadata=all&max-answer.dateOfAnswer=2019-02-06", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answer.dateOfAnswer=2016-05-04&tablingMemberConstituency=Reigate&max-answer.dateOfAnswer=2019-02-06", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2016-05-04&tablingMemberConstituency=Reigate&max-answer.dateOfAnswer=2019-02-06", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.dateOfAnswer=2016-05-04&tablingMemberConstituency=Reigate&max-answer.dateOfAnswer=2019-02-06", "items" : [{"_about" : "http://data.parliament.uk/resources/515783", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/515783/answer", "answerText" : {"_value" : "

The Government does not target individuals based on their actual or perceived sexual orientation. Common Article 3 prohibits adverse distinction founded on race, colour religion or faith, sex, birth or wealth, or any other similar criteria.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4017", "label" : {"_value" : "Biography information for Penny Mordaunt"} } , "answeringMemberConstituency" : {"_value" : "Portsmouth North"} , "answeringMemberPrinted" : {"_value" : "Penny Mordaunt"} , "dateOfAnswer" : {"_value" : "2016-05-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-05-04T13:58:36.013Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2016-04-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Armed Conflict: Sexuality"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Defence, what the Government's policy is on (a) including within Common Article 3 of the Geneva Conventions 1949 prohibition of the targeting of individuals based on actual or perceived sexual orientation and (b) whether the consequences under international law of targeting individuals on the ground of sexual orientation are the same as targeting on the grounds of race, colour, religion or faith, sex and birth or wealth.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/104", "label" : {"_value" : "Biography information for Crispin Blunt"} } , "tablingMemberConstituency" : {"_value" : "Reigate"} , "tablingMemberPrinted" : [{"_value" : "Crispin Blunt"} ], "uin" : "35741"} , {"_about" : "http://data.parliament.uk/resources/515951", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/515951/answer", "answerText" : {"_value" : "

NHS England has agreed to carefully consider their position on commissioning pre-exposure prophylaxis (PrEP). Planning continues on the early implementer tests sites in the meantime. Irrespective of the commissioning arrangements for PrEP, decisions to fund will depend on full assessment of clinical and cost effectiveness and how it can be integrated with other HIV prevention efforts.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2016-05-04", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2016-05-04T08:26:07.877Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2016-04-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what further discussions his Department plans to hold with industry and other interested parties on the decision of NHS England to end the specialised commissioning process for HIV medicines used for Pre-Exposure Prophylaxis; what plans he has for the provision of such medicines before the end of the current pilot of early implementer sites over the next two years; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/104", "label" : {"_value" : "Biography information for Crispin Blunt"} } , "tablingMemberConstituency" : {"_value" : "Reigate"} , "tablingMemberPrinted" : [{"_value" : "Crispin Blunt"} ], "uin" : "35694"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }